Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition
Saved in:
| Main Authors: | Stephanie Ling, Alex Dexter, Alan M. Race, Shreya Sharma, Gregory Hamm, Urszula M. Polanska, Rosetta Consortium Cancer Research UK, John F. Marshall, Zoltan Takats, Kevin Brindle, Mariia O. Yuneva, George Poulogiannis, Andrew D. Campbell, Owen J. Sansom, Richard J. A. Goodwin, Josephine Bunch, Simon T. Barry |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Company of Biologists
2025-02-01
|
| Series: | Disease Models & Mechanisms |
| Subjects: | |
| Online Access: | http://dmm.biologists.org/content/18/2/DMM050804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mTORC1 and mTORC2 synergy in human neural development, disease, and regeneration
by: Navroop K. Dhaliwal, et al.
Published: (2026-04-01) -
RAB3B Dictates mTORC1/S6 Signaling in Chordoma and Predicts Response to mTORC1‐Targeted Therapy
by: Jianxuan Gao, et al.
Published: (2025-05-01) -
A Method for Borehole Image Reverse Positioning and Restoration Based on Grayscale Characteristics
by: Shuangyuan Chen, et al.
Published: (2024-12-01) -
In situ imaging of microplastics in living organisms based on mass spectrometry technology
by: Ye Li, et al.
Published: (2024-12-01) -
Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
by: Uma K Misra, et al.
Published: (2012-01-01)